Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

PHXM

PHAXIAM Therapeutics (PHXM)

PHAXIAM Therapeutics SA
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PHXM
FechaHoraFuenteTítuloSímboloCompañía
11/03/202407:31Edgar (US Regulatory)Form 15F-12B - Securities registration termination of foreign private issuers [Section 12(b)]NASDAQ:PHXMPHAXIAM Therapeutics SA
11/03/202401:00GlobeNewswire Inc.PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketNASDAQ:PHXMPHAXIAM Therapeutics SA
05/03/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PHXMPHAXIAM Therapeutics SA
04/03/202415:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PHXMPHAXIAM Therapeutics SA
04/03/202415:09Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:PHXMPHAXIAM Therapeutics SA
21/02/202405:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHXMPHAXIAM Therapeutics SA
20/02/202415:05GlobeNewswire Inc.PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketNASDAQ:PHXMPHAXIAM Therapeutics SA
18/01/202415:05GlobeNewswire Inc.PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024NASDAQ:PHXMPHAXIAM Therapeutics SA
14/11/202315:05GlobeNewswire Inc.PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023NASDAQ:PHXMPHAXIAM Therapeutics SA
24/10/202315:05GlobeNewswire Inc.PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureusNASDAQ:PHXMPHAXIAM Therapeutics SA
23/10/202315:05GlobeNewswire Inc.TP ICAP Midcap initiates coverage of PHAXIAM Therapeutics with a “Buy” recommendationNASDAQ:PHXMPHAXIAM Therapeutics SA
 Showing the most relevant articles for your search:NASDAQ:PHXM